MedTrace Logo

Immune Cell Dysfunction in Severe Alcoholic Hepatitis

NCT02275195 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-01-12

No results posted yet for this study

Summary

Through bio-sampling this study investigates the relationship between the frequency and function of the cells of a patients immune system and how these change and impact on the outcome of alcoholic hepatitis. the investigators will examine the role of different cells of the immune system and how they may determine the outcome of this condition. The investigators will also look at how established treatment strategies impact on the frequency and function of these cell subsets.

Conditions

  • Hepatitis

Sponsors & Collaborators

  • Mid and South Essex NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Gavin Wright, MBBS MRCP · Basildon and Thurrock University Hospitals NHS FT

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275195 on ClinicalTrials.gov